EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oncogene-induced matrix reorganization controls CD8+ T cell function in the soft-tissue sarcoma microenvironment

Ashley M Fuller, Hawley C Pruitt, Ying Liu, Valerie M Irizarry-Negron, Hehai Pan, Hoogeun Song, Ann DeVine, Rohan S Katti, Samir Devalaraja, Gabrielle E Ciotti, Michael V Gonzalez, Erik F Williams und 12 weitere

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci167826 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Ashley M Fuller und 23 weiteren Autor:innen. Beteiligte Einrichtung: Abramson Family Cancer Research Institute, Department of Pathology and Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Tumor Microenvironment, YAP-Signaling Proteins, Extracellular Matrix. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD8 + T cell dysfunction impedes antitumor immunity in solid cancers, but the underlying mechanisms are diverse and poorly understood. Extracellular matrix (ECM) composition has been linked to impaired T cell migration and enhanced tumor progression; however, impacts of individual ECM molecules on T cell function in the tumor microenvironment (TME) are only beginning to be elucidated. Upstream regulators of aberrant ECM deposition and organization in solid tumors are equally ill-defined. Therefore, we investigated how ECM composition modulates CD8 + T cell function in undifferentiated pleomorphic sarcoma (UPS), an immunologically active desmoplastic tumor. Using an autochthonous murine model of UPS and data from multiple human patient cohorts, we discovered a multifaceted mechanism wherein the transcriptional coactivator YAP1 promotes collagen VI (COLVI) deposition in the UPS TME. In turn, COLVI induces CD8 + T cell dysfunction and immune evasion by remodeling fibrillar collagen and inhibiting T cell autophagic flux. Unexpectedly, collagen I (COLI) opposed COLVI in this setting, promoting CD8 + T cell function and acting as a tumor suppressor. Thus, CD8 + T cell responses in sarcoma depend on oncogene-mediated ECM composition and remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesTumor MicroenvironmentYAP-Signaling ProteinsExtracellular MatrixSarcomaAnimalsMiceHumansCollagen Type VIAdaptor Proteins, Signal TransducingTranscription FactorsOncogenesNeoplasm ProteinsCollagen Type I

Stichwörter der Autor:innen

Cancer immunotherapyExtracellular matrixOncologySkeletal muscle

Substanzen

YAP-Signaling ProteinsCollagen Type VIYAP1 protein, humanYap1 protein, mouseAdaptor Proteins, Signal TransducingTranscription FactorsNeoplasm ProteinsCollagen Type I

Autor:innen und Institutionen

  • Abramson Family Cancer Research Institute, Department of Pathology and Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Chemical and Biomolecular Engineering, Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland, USA.
  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Microbiology, Center for Cellular Immunotherapies, Parker Institute for Cancer Immunotherapy, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Biomedical Engineering, Duke University, Durham, North Carolina, USA.
  • Department of Oncology, The Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • NIAID NIH HHS
  • NIH HHS
  • NHLBI NIH HHS
  • The University of Pennsylvania Abramson Cancer Center
  • The Penn Sarcoma Program
  • Steps to Cure Sarcoma

Zitieren

APA

Fuller, A. M., Pruitt, H. C., Liu, Y., Irizarry-Negron, V. M., Pan, H., Song, H., DeVine, A., Katti, R. S., Devalaraja, S., Ciotti, G. E., Gonzalez, M. V., Williams, E. F., Murazzi, I., Ntekoumes, D., Skuli, N., Hakonarson, H., Zabransky, D. J., Trevino, J. G., Weeraratna, A., …, & Eisinger-Mathason, T. S. K. (2024). Oncogene-induced matrix reorganization controls CD8+ T cell function in the soft-tissue sarcoma microenvironment. Journal of Clinical Investigation. https://doi.org/10.1172/jci167826

Vancouver

Fuller AM, Pruitt HC, Liu Y, Irizarry-Negron VM, Pan H, Song H, et al. Oncogene-induced matrix reorganization controls CD8+ T cell function in the soft-tissue sarcoma microenvironment. Journal of Clinical Investigation. 2024. doi:10.1172/jci167826

BibTeX
@article{Fuller2024,
  author = {Fuller, Ashley M and Pruitt, Hawley C and Liu, Ying and Irizarry-Negron, Valerie M and Pan, Hehai and Song, Hoogeun and DeVine, Ann and Katti, Rohan S and Devalaraja, Samir and Ciotti, Gabrielle E and Gonzalez, Michael V and Williams, Erik F and Murazzi, Ileana and Ntekoumes, Dimitris and Skuli, Nicolas and Hakonarson, Hakon and Zabransky, Daniel J and Trevino, Jose G and Weeraratna, Ashani and Weber, Kristy and Haldar, Malay and Fraietta, Joseph A and Gerecht, Sharon and Eisinger-Mathason, T S Karin},
  title = {Oncogene-induced matrix reorganization controls CD8+ T cell function in the soft-tissue sarcoma microenvironment},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci167826}
}
Kostenlos starten →